Joelsons G, Domenico T, Goncalves L, Manfro R
Braz J Med Biol Res. 2018; 51(7):e6904.
PMID: 29791589
PMC: 5972022.
DOI: 10.1590/1414-431x20186904.
Boer K, de Wit L, Peters F, Hesselink D, Hofland L, Betjes M
Clin Epigenetics. 2016; 8:116.
PMID: 27891189
PMC: 5112717.
DOI: 10.1186/s13148-016-0288-0.
Zhang L, Moffatt-Bruce S, Gaughan A, Wang J, Rajab A, Hadley G
Am J Transplant. 2009; 9(9):2012-23.
PMID: 19645708
PMC: 3190194.
DOI: 10.1111/j.1600-6143.2009.02735.x.
Feng Y, Wang D, Yuan R, Parker C, Farber D, Hadley G
J Exp Med. 2002; 196(7):877-86.
PMID: 12370250
PMC: 2194029.
DOI: 10.1084/jem.20020178.
Lin Y, Proud G, Taylor R, Kirby J
Immunology. 1993; 79(2):290-7.
PMID: 8344707
PMC: 1421859.
Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients.
Foster C, Wu H, Merchant A
Doc Ophthalmol. 1993; 83(1):83-9.
PMID: 8334924
DOI: 10.1007/BF01203574.
Effector cells in allelic H-2 class I-incompatible skin graft rejection.
Ichikawa T, Nakayama E, Uenaka A, Monden M, Mori T
J Exp Med. 1987; 166(4):982-90.
PMID: 3309129
PMC: 2188715.
DOI: 10.1084/jem.166.4.982.
Corneal allograft rejection in bilateral penetrating keratoplasty: clinical and laboratory studies.
Meyer R
Trans Am Ophthalmol Soc. 1986; 84:664-742.
PMID: 3296407
PMC: 1298750.
A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the MEL-14-defined lymph node homing receptor.
Mueller C, Gershenfeld H, Lobe C, Okada C, Bleackley R, Weissman I
J Exp Med. 1988; 167(3):1124-36.
PMID: 3280725
PMC: 2188904.
DOI: 10.1084/jem.167.3.1124.
Rat heterotopic heart transplantation: quantification and analysis of cell mediated cytotoxicity.
Kirby J, Reader J, Parfett G, Pepper J
Clin Exp Immunol. 1988; 71(1):113-9.
PMID: 3280177
PMC: 1541647.
Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis.
Widner H, Brundin P
Brain Res. 1988; 472(3):287-324.
PMID: 3066438
PMC: 7133672.
DOI: 10.1016/0165-0173(88)90010-0.
T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.
Moreau J, Bonneville M, Peyrat M, Godard A, Jacques Y, Desgranges C
J Clin Invest. 1986; 78(4):874-9.
PMID: 3020092
PMC: 423705.
DOI: 10.1172/JCI112674.
Cellular requirements for renal allograft rejection in the athymic nude rat.
Bolton E, Gracie J, Briggs J, Kampinga J, Bradley J
J Exp Med. 1989; 169(6):1931-46.
PMID: 2659723
PMC: 2189330.
DOI: 10.1084/jem.169.6.1931.
T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection.
Auchincloss Jr H, Mayer T, Ghobrial R, Winn H
Immunol Res. 1989; 8(2):149-64.
PMID: 2659690
DOI: 10.1007/BF02919076.
Evidence that the effector mechanism of skin allograft rejection is antigen-specific.
Rosenberg A, Singer A
Proc Natl Acad Sci U S A. 1988; 85(20):7739-42.
PMID: 2459716
PMC: 282268.
DOI: 10.1073/pnas.85.20.7739.
Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
Rosenberg A, Mizuochi T, Sharrow S, Singer A
J Exp Med. 1987; 165(5):1296-315.
PMID: 2437237
PMC: 2188316.
DOI: 10.1084/jem.165.5.1296.
Tumour-induced immunity to H-Y-disparate skin grafts without concomitant priming of CTL.
Johnson L, Hines D
Immunology. 1990; 69(1):85-90.
PMID: 2312158
PMC: 1385724.
Allograft rejection in athymic nude rats by transferred T-cell subsets. I. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to complete allogeneic incompatibilities.
Whitby E, Sparshott S, Bell E
Immunology. 1990; 69(1):78-84.
PMID: 2138126
PMC: 1385723.
OKT3 prophylaxis in liver transplantation.
McDiarmid S, Millis M, Terasaki P, Ament M, Busuttil R
Dig Dis Sci. 1991; 36(10):1418-26.
PMID: 1833167
DOI: 10.1007/BF01296809.
Skin graft rejection by beta 2-microglobulin-deficient mice.
Zijlstra M, Auchincloss Jr H, LORING J, Chase C, Russell P, Jaenisch R
J Exp Med. 1992; 175(4):885-93.
PMID: 1552287
PMC: 2119179.
DOI: 10.1084/jem.175.4.885.
